Suramin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Half-lifeThis section has been translated automatically.

40 days.

IndicationThis section has been translated automatically.

Hemolymphatic stage of African sleeping sickness, river blindness.

Limited indicationThis section has been translated automatically.

Malnutrition, kidney damage.

Dosage and method of useThis section has been translated automatically.

1 g slowly i.v. on days 1, 3, 7, 14 and 21.

Remember! At the beginning of the therapy, a test dose of 10-20 mg should be administered slowly IV!

Undesirable effectsThis section has been translated automatically.

Local reactions at the injection site, vomiting, pruritus, urticaria, paraesthesia, hyperaesthesia of hands and feet, photophobia, peripheral neuropathies, gastrointestinal disorders, fever, headache and aching limbs.

PreparationsThis section has been translated automatically.

Germanine, Naphuride (both preparations are only available through international pharmacies).

Authors

Last updated on: 29.10.2020